Your browser doesn't support javascript.
loading
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
Pineda-Peña, Andrea-Clemencia; Schrooten, Yoeri; Vinken, Lore; Ferreira, Fossie; Li, Guangdi; Trovão, Nídia Sequeira; Khouri, Ricardo; Derdelinckx, Inge; De Munter, Paul; Kücherer, Claudia; Kostrikis, Leondios G; Nielsen, Claus; Littsola, Kirsi; Wensing, Annemarie; Stanojevic, Maja; Paredes, Roger; Balotta, Claudia; Albert, Jan; Boucher, Charles; Gomez-Lopez, Arley; Van Wijngaerden, Eric; Van Ranst, Marc; Vercauteren, Jurgen; Vandamme, Anne-Mieke; Van Laethem, Kristel.
Afiliação
  • Pineda-Peña AC; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Clinical and Molecular Infectious Diseases Group, Faculty of Sciences and Mathematics, Universidad del Rosario, Bogotá, Colombia.
  • Schrooten Y; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; AIDS Reference Laboratory, University Hospitals Leuven, Leuven, Belgium.
  • Vinken L; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Ferreira F; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Li G; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Trovão NS; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Khouri R; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Derdelinckx I; Clinical Infectious and Inflammatory Disorders, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • De Munter P; Clinical Infectious and Inflammatory Disorders, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Kücherer C; Robert Koch-Institut, Berlin, Germany.
  • Kostrikis LG; University of Cyprus, Nicosia, Cyprus.
  • Nielsen C; Statens Serum Institut, Copenhagen, Denmark.
  • Littsola K; National Institute of health and welfare, Helsinki, Finland.
  • Wensing A; Department of Virology, University Medical Center Utrecht, The Netherlands.
  • Stanojevic M; University of Belgrade, Faculty of Medicine, Belgrade, Serbia.
  • Paredes R; IrsiCaixa Foundation, Badalona, Spain.
  • Balotta C; Luigi Sacco University Hospital, Milan, Italy.
  • Albert J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
  • Boucher C; Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Gomez-Lopez A; Clinical and Molecular Infectious Diseases Group, Faculty of Sciences and Mathematics, Universidad del Rosario, Bogotá, Colombia.
  • Van Wijngaerden E; Clinical Infectious and Inflammatory Disorders, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Internal Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Van Ranst M; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; AIDS Reference Laboratory, University Hospitals Leuven, Leuven, Belgium.
  • Vercauteren J; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Vandamme AM; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Centro de Malária e outras Doenças Tropicais and Unidade de Microbiologia, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa,
  • Van Laethem K; Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; AIDS Reference Laboratory, University Hospitals Leuven, Leuven, Belgium.
PLoS One ; 9(7): e101738, 2014.
Article em En | MEDLINE | ID: mdl-25003369
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Farmacorresistência Viral Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged / Pregnancy País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Farmacorresistência Viral Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged / Pregnancy País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos